Target intelligence / Profile preview

DnaJ heat shock protein family member B13 (DNAJB13)

Target
DNAJB13
Molecular classification
Heat shock protein (Hsp40 family), Co-chaperone, Axonemal radial spoke complex protein, Chaperone
01

Overview

DnaJ heat shock protein family member B13 (DNAJB13) is a type II Hsp40 co-chaperone protein highly expressed in testis and essential for the structure and motility of cilia and sperm flagella[2][3]. It localizes to the radial spokes of the axoneme—an internal scaffold in flagella/cilia—and plays a key role in stabilizing and assembling these structures, which are fundamental for sperm movement and ciliary beating in respiratory epithelia[2][3][1]. DNAJB13 interacts with septin 4 in the sperm annulus and is required during terminal sperm differentiation. Loss-of-function variants are directly linked to primary ciliary dyskinesia—a disorder of dysfunctional cilia leading to respiratory disease—and to male infertility, primarily via abnormal sperm motility (asthenozoospermia) and morphology[2][3][1]. There is no evidence DNAJB13 is a direct target of pharmacological agents. Rather, its clinical relevance is as a genetic cause of ciliopathies and infertility, and as a biomarker in these contexts[2][3].

Other names
DnaJ (Hsp40) homolog, subfamily B, member 13DNAJB13TSARG3TSARG6RSPH16ATestis spermatogenesis apoptosis-related gene 3 proteinTestis spermatogenesis apoptosis-related gene 6 proteinTestis spermatocyte apoptosis-related gene 6 proteinTestis and spermatogenesis cell-related protein 6radial spoke 16 homolog ACILD34DnaJ-like protein
02

Mechanism of action

Not applicable. No drugs or small molecules with defined mechanism of action targeting DNAJB13[3][2].

03

Biological functions

Protein foldingChaperone activity (regulating proper folding of client proteins)Motile cilia assembly and functionSperm flagellum assembly and regulationSpermiogenesis (sperm cell development)Structural stabilization of radial spoke (in axoneme of flagella/cilia)
04

Disease associations

Primary ciliary dyskinesiaMale infertility (asthenozoospermia, teratozoospermia)Other cilia-related disorders
05

Safety considerations

None directly reported. As DNAJB13 is not a therapeutic target, there are no known safety concerns associated with its modulation[3][2]. Potential issues would be related to loss-of-function, not therapeutic inhibition.
06

Biomarkers

DNAJB13 mutation or loss-of-function may serve as *molecular marker* for primary ciliary dyskinesia[2][1][3].Possible biomarker in studies of male infertility due to ciliary defects[2][3].

Beyond the preview

Go deeper on DnaJ heat shock protein family member B13 (DNAJB13).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on DnaJ heat shock protein family member B13 (DNAJB13).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call